Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model | Labcorp Oncology Skip to main contentScroll Back to Top
Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model
Poster
Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model
Draper, Derrik Germain, Stacey Roys, Olivia Nelson and Scott Wise; Labcorp Early Development Laboratories Inc., Ann Arbor, MI